Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.-论文-万方医学网

作者： Paul J,Pockros ^[1] ; K Rajender,Reddy ^[2] ; Parvez S,Mantry ^[3] ; Eric,Cohen ^[4] ; Michael,Bennett ^[5] ; Mark S,Sulkowski ^[6] ; David E,Bernstein ^[7] ; Daniel E,Cohen ^[4] ; Nancy S,Shulman ^[8] ; Deli,Wang ^[9] ; Amit,Khatri ^[10] ; Manal,Abunimeh ^[4] ; Thomas,Podsadecki ^[8] ; Eric,Lawitz ^[11]

作者单位： Division of Gastroenterology/Hepatology, Scripps Clinic and Scripps Translational Science Institute, La Jolla, California. ^[1] Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania. ^[2] The Liver Institute at Methodist Dallas, Dallas, Texas. ^[3] Infectious Disease Development, AbbVie Inc, North Chicago, Illinois. ^[4] Medical Associates Research Group, San Diego, California. ^[5] Division of Infectious Diseases and Gastroenterology/Hepatology, Johns Hopkins University, Baltimore, Maryland. ^[6] Division of Gastroenterology, North Shore University Hospital, Manhasset, New York. ^[7] Global Pharmaceutical Development, AbbVie Inc, North Chicago, Illinois. ^[8] Statistics and Computer Sciences, AbbVie Inc, North Chicago, Illinois. ^[9] Clinical Pharmacokinetics, AbbVie Inc, North Chicago, Illinois. ^[10] Department of Gastroenterology, The Texas Liver Institute, University of Texas Health Science Center, San Antonio, Texas. Electronic address: lawitz@txliver.com. ^[11]

主题词 2-萘胺(2-Naphthylamine);老年人(Aged);酰苯胺类(Anilides);抗病毒药(Antiviral Agents);氨甲酸酯类(Carbamates);环丙烷类(Cyclopropanes);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);基因型(Genotype);肝炎病毒属(Hepacivirus);丙型肝炎(Hepatitis C);人类(Humans);肾功能衰竭, 慢性(Kidney Failure, Chronic);内酰胺类, 大环(Lactams, Macrocyclic);大环化合物(Macrocyclic Compounds);男(雄)性(Male);中年人(Middle Aged);脯氨酸(Proline);前瞻性研究(Prospective Studies);利巴韦林(Ribavirin);利托纳韦(Ritonavir);磺胺类(Sulfonamides);尿嘧啶(Uracil);缬氨酸(Valine)

DOI 10.1053/j.gastro.2016.02.078

PMID 26976799

发布时间 2022-03-31

检索历史清除

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.

Gastroenterology

相似文献

Gastroenterology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.

Gastroenterology

相似文献

Gastroenterology

相关期刊

检索历史清除